|
LOC729603 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.22170000016864E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.154120E-04 |
| Normal-vs-Stage2 |
2.338500E-02 |
| Normal-vs-Stage3 |
5.445800E-01 |
| Normal-vs-Stage4 |
6.917200E-01 |
| Stage1-vs-Stage2 |
6.422200E-01 |
| Stage1-vs-Stage3 |
1.143860E-02 |
| Stage1-vs-Stage4 |
8.722400E-02 |
| Stage2-vs-Stage3 |
6.286100E-02 |
| Stage2-vs-Stage4 |
7.008100E-02 |
| Stage3-vs-Stage4 |
4.949000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.73959999972118E-07 |
| Normal-vs-AfricanAmerican |
5.808400E-04 |
| Normal-vs-Asian |
8.617900E-02 |
| Caucasian-vs-AfricanAmerican |
8.939600E-01 |
| Caucasian-vs-Asian |
2.845700E-02 |
| AfricanAmerican-vs-Asian |
4.435800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.27360000049082E-07 |
| Normal-vs-Female |
5.316500E-03 |
| Male-vs-Female |
2.492400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.885900E-02 |
| Normal-vs-Extreme_Weight |
9.559400E-03 |
| Normal-vs-Obese |
2.23969999999518E-05 |
| Normal-vs-Extreme_Obese |
2.884000E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.257000E-01 |
| Normal_Weight-vs-Obese |
1.544630E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.939200E-01 |
| Extreme_Weight-vs-Obese |
2.399900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.006180E-01 |
| Obese-vs-Extreme_Obese |
7.963200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.904600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.83379999863354E-08 |
| Normal-vs-Age(61-80Yrs) |
1.182920E-04 |
| Normal-vs-Age(81-100Yrs) |
2.098200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.060700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.416300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.320200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.294230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.890780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.699600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.53339998873759E-09 |
| Normal-VS-Type2 PRCC |
9.255700E-02 |
| Normal-VS-KIRP CIMP |
4.572400E-01 |
| Normal-VS-Unclassified PRCC |
5.542000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.371630E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.146320E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.670400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.998570E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.026300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.931900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.505670E-02 |
| Normal-vs-N1 |
7.387600E-02 |
| Normal-vs-N2 |
8.840800E-01 |
| N0-vs-N1 |
8.487600E-01 |
| N0-vs-N2 |
5.870200E-01 |
| N1-vs-N2 |
6.407000E-01 |
|
|
